KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBT Margin (2016 - 2026)

Merck has reported EBT Margin over the past 18 years, most recently at 21.49% for Q1 2026.

  • Quarterly EBT Margin fell 5950.0% to 21.49% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 17.74% through Mar 2026, down 1382.0% year-over-year, with the annual reading at 32.41% for FY2025, 134.0% up from the prior year.
  • EBT Margin was 21.49% for Q1 2026 at Merck, down from 20.85% in the prior quarter.
  • Over five years, EBT Margin peaked at 39.04% in Q3 2025 and troughed at 35.25% in Q2 2023.
  • The 5-year median for EBT Margin is 26.69% (2024), against an average of 20.84%.
  • Year-over-year, EBT Margin tumbled -6600bps in 2023 and then skyrocketed 7253bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 25.4% in 2022, then plummeted by -155bps to 13.98% in 2023, then skyrocketed by 291bps to 26.69% in 2024, then decreased by -22bps to 20.85% in 2025, then plummeted by -203bps to 21.49% in 2026.
  • Per Business Quant, the three most recent readings for MRK's EBT Margin are 21.49% (Q1 2026), 20.85% (Q4 2025), and 39.04% (Q3 2025).